Research progress in catalytic combustion of organic waste gas in pharmaceutical industry

被引:0
|
作者
Meng X. [1 ]
Zhuang R. [1 ]
Yu Q. [1 ,2 ]
Tang X. [1 ,2 ]
Yi H. [1 ,2 ]
Feng Y. [1 ]
Wei J. [1 ]
Chen C. [1 ]
机构
[1] School of Energy and Environmental Engineering, University of Science and Technology Beijing, Beijing
[2] Beijing Key Laboratory of Resource-oriented Treatment of Industrial Pollutants, Beijing
关键词
Catalyst; Catalytic combustion; Pharmaceutical industry; Volatile organic compounds(VOCs);
D O I
10.16085/j.issn.1000-6613.2020-0722
中图分类号
学科分类号
摘要
The rapid development of the pharmaceutical industry in China brought economic growth and convenience to life, as well as large volatile organic pollutants (VOCs) emission. Among various VOCs purification methods, catalytic combustion is considered as a good one with favorable environmental friendliness and flexibility for purifying pharmaceutical VOCs which is characterized by the large emission, multiple emission nodes, and complex types of pollutants. In this paper, typical volatile organic compounds emitted from the pharmaceutical industry and the characteristics of these pollutants were summarized. Based on this, the development and application of catalytic materials in the catalytic combustion of pharmaceutical VOCs in recent years were further summarized. Meanwhile, the prospect of organic waste gas treatment in China's pharmaceutical industry was proposed. Firstly, more in-depth researches such as pharmaceutical VOCs emission characterization and laboratory scale VOCs purification should be performed to ensure the economic effectiveness in the actual purification process. Secondly, new process coupling multi-technology should be developed to improve the purification efficiency to meet the pharmaceutical industry exhaust emission standards in China. © 2021, Chemical Industry Press Co., Ltd. All right reserved.
引用
收藏
页码:789 / 799
页数:10
相关论文
共 57 条
  • [1] JIANG M X, XIAO L F, CAI Y X., The current treatments of VOCs in pharmaceutical industries, Environmental Impact Assessment, 37, 5, pp. 92-96, (2015)
  • [2] WANG D S, ZHU X M, YANG X F, Et al., Advances and perspectives in pollution characteristics and prevention and control technology of VOCs and odor emitted from pharmaceutical fermentation industry, Environmental Science, 4, pp. 1-12, (2019)
  • [3] XU Z R, WANG Z M, XU M Z, Et al., Health risk assessment and ozone formation potentials of volatile organic compounds from pharmaceutical industry in Zhejiang Province, Environmental Science, 34, 5, pp. 1864-1870, (2013)
  • [4] WANG H H, XING S B, ZHOU B H, Et al., Current situation of pharmaceutical industry pollution control and its countermeasures in Hebei, Hebei Industrial Technology, 27, 5, pp. 355-360, (2010)
  • [5] ZHAO X H, GUO B Z, ZHAO X F., Study on source analysis and prevention technology of organic waste gas in chemical synthesis pharmaceutical industry, Henan Science and Technology, 14, pp. 46-47, (2014)
  • [6] XING S B, XIU G L, CHEN Y Q., The pollution characterization and control standard of pollutants from pharmaceutical manufacturer, Environmental Science and Management, 34, 10, pp. 8-13, (2009)
  • [7] WANG D S, ZHU X M, YANG X F, Et al., Status and prospect of VOCs and odor pollution characteristics and prevention and control technology in biological fermentation pharmaceutical industry, Environmental Science, 40, 4, pp. 1990-1998, (2019)
  • [8] ZHANG T., Study on the emission characteristics of VOCs and odor pollutants from the pharmaceutical industry and the establishment of the database in Shijiazhuang, (2014)
  • [9] LI Y., Study on emission standard of air pollutants for pharmaceutical industry chemical synthesis products category, (2015)
  • [10] HU J, ZHANG L L, CHEN J M, Et al., Performance and microbial analysis of a biotrickling filter inoculated by a specific bacteria consortium for removal of a simulated mixture of pharmaceutical volatile organic compounds, Chemical Engineering Journal, 304, pp. 757-765, (2016)